Haw ParHAWPF 93 PS Ratio is 14.85 as of Jul. 04, 2026, which is 23% above its 10-year median of 12.06. GuruFocus rates HAWPF with a GF Score™ of 93/100 and a GF Value™ of $8.94. The stock has 3 warning signs investors should review. Among 950 Drug Manufacturers companies, Haw Par ranks worse than 91.79% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Haw Par's share price is $12.00.
Haw Par's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.81. Hence, Haw Par's PS Ratio for today is 14.85.
The historical rank and industry rank for Haw Par's PS Ratio or its related term are showing as below:
HAWPF'
s PS Ratio Range Over the Past 10 Years
Min: 8.31 Med: 12.06 Max: 27.19
Current: 15.25
During the past 13 years, Haw Par's highest PS Ratio was 27.19. The lowest was 8.31. And the median was 12.06.
HAWPF's PS Ratio is ranked worse than 91.79% of 950
companies
in the Drug Manufacturers industry
Industry Median: 2.315
vs HAWPF: 15.25
Haw Par's Revenue per Sharefor the
six
months ended in Dec. 2025 was $0.36.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.81.
Warning Sign:
Haw Par Corp Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Haw Par was -6.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 8.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 17.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 0.90% per year.
During the past 13 years, Haw Par's highest 3-Year average Revenue per Share Growth Rate was 27.80% per year. The lowest was -20.80% per year. And the median was 4.25% per year.
Back to Basics: PS Ratio
Haw Par (OTCPK:HAWPF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Haw Par PS Ratio Related Terms
Haw Par PS Ratio Historical Data
* Premium members only.
The historical data trend for Haw Par's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Haw Par's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's PS Ratio distribution charts can be found below:
* The bar in red indicates where Haw Par's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Haw Par's Share Price of today is $12.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Haw Par's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.81.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Haw Par (HAWPF) has a PS Ratio of 14.85 as of Jul. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Haw Par and its competitors. This is 23% above median its historical median of 12.06. Over the past decade, Haw Par's PS Ratio has ranged from 8.31 to 27.19. According to the industry distribution chart, Haw Par ranks #872 out of 950 companies in the Drug Manufacturers industry, placing it in the top 91.8%.
Is Haw Par's PS Ratio too high?
Haw Par's current PS Ratio of 14.85 is 23% above median its 10-year median of 12.06. Over the past 10 years, this metric has ranged from a low of 8.31 to a high of 27.19. The Drug Manufacturers industry median PS Ratio is 2.32. Haw Par's value of 14.85 is 541.5% above this industry median. Based on the distribution chart, Haw Par ranks #872 out of 950 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Haw Par has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Haw Par's PS Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Haw Par ranks #872 out of 950 companies for PS Ratio. This places Haw Par in the lower half of its industry. The industry median PS Ratio is 2.32. Haw Par's value of 14.85 is 541.5% above this benchmark. Historically, Haw Par's own PS Ratio has ranged from 8.31 to 27.19 over the past decade. While the company's 10-year median is 12.06 vs. the industry median of 2.32, Haw Par has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.32, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haw Par's current PS Ratio of 14.85 is 541.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Haw Par and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haw Par's current PS Ratio is 14.85, which is 23% above median its own 10-year median of 12.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haw Par stock overvalued right now?
Haw Par (HAWPF) has a current PS Ratio of 14.85. The stock's GF Value™ is $8.94, compared to a current price of $12.00 — trading 34.2% above its estimated fair value. The current PS Ratio is 14.85, which is 23% above median its 10-year median of 12.06 and 541.5% above the Drug Manufacturers industry median of 2.32. Haw Par's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Haw Par (HAWPF), the current PS Ratio is 14.85 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haw Par (HAWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Haw Par stock appears to be overvalued.
The current stock price of $12.00 is trading 34.2% above its estimated GF Value™ of $8.94.
Key valuation signals for HAWPF:
PS Ratio: 14.85 (23% above median its 10-year median of 12.06)
GF Value™: $8.94 vs. price of $12.00 (34.2% above fair value)
Industry Position: 541.5% above the Drug Manufacturers median (#872 of 950)
No single metric tells the full story. See the HAWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
93GF Score
Get the complete analysis for HAWPF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAWPF has been successfully added to your 
